KNK437
|
KNK437
|
218924-25-5
|
K-Ras(G12C) inhibitor 9
|
K-Ras(G12C) inhibitor 9
|
1469337-91-4
|
KU-60019
|
KU-60019
|
925701-49-1
|
KW-2449 HCl
|
[4-[2-(1H-吲唑-3-基)乙烯基]苯基]-1-哌嗪基甲酮
|
1000669-72-6
|
L-67
|
|
325970-71-6
|
LAQ824
|
达诺司他
|
404951-53-7
|
Laropiprant(MK-0524)
|
LAROPIPRANT
|
571170-77-9
|
LDN193189 HCl
|
LDN-193189 HCl
|
1062368-62-0
|
LJH685
|
2,6-二氟-4-[4-[4-(4-甲基-1-哌嗪基)苯基]-3-吡啶基]苯酚
|
1627710-50-2
|
LJI-308
|
LJI308
|
1627709-94-7
|
LLY-507
|
LLY-507
|
1793053-37-8
|
Lomeguatrib (PaTrin-2)
|
罗米鲁曲
|
192441-08-0
|
Losartan Carboxylic Acid
|
氯沙坦羧酸
|
124750-92-1
|
LRRK2-IN-1
|
5,11-二氢-2-[[2-甲氧基-4-[[4-(4-甲基-1-哌嗪基)-1-哌啶基]羰基]苯基]氨基]-5,11-二甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮
|
1234480-84-2
|
LSN2814617
|
LSN2814617消旋体
|
1313498-08-6
|
LY2157299
|
LY 2157299
|
700874-72-2
|
LY2608204
|
(1R,2S)-2-环己基-1-[4-(环丙基磺酰基)苯基]-N-[5-[[2-(1-吡咯烷基)乙基]硫代]-2-噻唑基]环丙烷甲酰胺
|
1234703-40-2
|
LY2835219(Abemaciclib)
|
阿贝西利
|
1231929-97-7
|
LY2886721
|
N-[3-[(4AS,7AS)-2-氨基-4A,5-二氢-4H-呋喃并[3,4-D][1,3]噻嗪-7A(7H)-基]-4-氟苯基]-5-氟-2-吡啶甲酰胺
|
1262036-50-9
|
LY310762
|
LY310762
|
192927-92-7
|
LY-411575
|
(AS)-N-[(1S)-2-[[(7S)-6,7-二氢-5-甲基-6-氧代-5H-二苯并[B,D]氮杂卓-7-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟-ALPHA-羟基苯乙酰胺
|
209984-57-6
|
Maraviroc (UK427857)
|
马拉维若
|
376348-65-1
|
Mavatrep(JNJ-39439335)
|
CS-1660
|
956274-94-5
|
MCC950 sodium
|
N-[[(1,2,3,5,6,7-六氢-S-引达省-4-基)氨基]羰基]-4-(1-羟基-1-甲基乙基)-2-呋喃磺酰胺单钠盐
|
256373-96-3
|
MHY1485
|
MHY1485
|
326914-06-1
|
MI-2(Menin-MLL Inhibitor)
|
2-氯-N-[4-[5-(3,4-二氯苯基)-3-(2-甲氧基乙氧基)-1H-1,2,4-三唑-1-基]苯基]乙酰胺
|
1047953-91-2
|
MI-3 (Menin-MLL Inhibitor)
|
MI-3 (Menin-MLL Inhibitor)
|
1271738-59-0
|
MK-0941
|
MK-0941
|
1137916-97-2
|
MK-2206 2HCl
|
MK-2206 2HCl
|
1032350-13-2
|
MK-571
|
MK-571 SODIUM HYDRATE
|
115103-85-0
|
MK-8776 (SCH 900776)
|
6-溴-3-(1-甲基-1H-吡唑-4-基)-5-(3R)-3-哌啶基吡唑并[1,5-A]嘧啶-7-胺
|
891494-63-6
|
ML-098
|
CS-1456
|
878978-76-8
|
ML-224
|
CS-1585
|
1338824-21-7
|
ML-241
|
ML241
|
1346528-06-0
|
ML-277
|
ML-277
|
1401242-74-7
|
ML347
|
(ML347)
|
1062368-49-3
|
ML365
|
ML-365
|
947914-18-3
|
ML-7 HCl
|
1-(5-碘萘-1-磺酰基)-1H-六氢-1,4-二氮杂卓盐酸盐
|
110448-33-4
|
MN-64
|
MN 64
|
92831-11-3
|
Moclobemide
|
吗氯贝胺
|
71320-77-9
|
Molidustat(BAY 85-3934)
|
MOLIDUSTAT
|
1154028-82-6
|
Motolimod (VTX-2337)
|
MOTOLIMOD
|
926927-61-9
|
MPEP hydrochloride
|
2-甲基-6-(苯基乙炔基)吡啶盐酸盐
|
219911-35-0
|
MPI-0479605
|
N6-环己基-N2-(2-甲基-4-吗啉苯基)-9H-嘌呤-2,6-二胺
|
1246529-32-7
|
MS023
|
N1-甲基-N1-[[4-[4-(异丙氧基)苯基]-1H-吡咯-3-基]甲基]-1,2-乙二胺
|
1831110-54-3
|
MSX 122
|
MSX 122
|
897657-95-3
|
Naloxegol Oxalate(NKTR-118)
|
聚乙二醇纳诺醇
|
1354744-91-4
|
Napabucasin (BBI608)
|
2-乙酰基呋喃并-1,4-萘醌
|
83280-65-3
|
Nepicastat HCl
|
盐酸内匹司他
|
170151-24-3
|
NG 52 (Compound 52 )
|
2-[[6-[(3-氯苯基)氨基]-9-异丙基-9H-嘌呤-2-基]氨基]乙醇
|
212779-48-1
|
NIBR189
|
NIBR189
|
1599432-08-2
|
NS 9283
|
NS 9283
|
913830-15-6
|
NS-398
|
抑制剂
|
123653-11-2
|
NS6180
|
NS-6180
|
353262-04-1
|
NSC348884
|
N1,N1,N2,N2-四[(6-甲基-1H-苯并咪唑-2-基)甲基]-1,2-乙二胺
|
81624-55-7
|
NSC-41589
|
化合物NSC-41589
|
6310-41-4
|
NSC59984
|
1-(4-甲基-1-哌嗪基)-3-(5-硝基-2-呋喃基)-2-丙烯-1-酮
|
803647-40-7
|
nu7026
|
2-(4-吗啉基)-4H-萘并[1,2-B]吡喃-4-酮
|
154447-35-5
|
NVP-ACC-789
|
N-(3-溴-4-甲基苯基)-4-(4-吡啶甲基)-1-酞嗪胺
|
300842-64-2
|
NVP-TAE684
|
NVP-TAE684
|
761439-42-3
|
OAC1
|
N-1H-吡咯并[2,3-C]吡啶-5-基苯甲酰胺
|
300586-90-7
|
OAC2
|
OAC2
|
6019-39-2
|
OF-1
|
OF-1
|
919973-83-4
|
ON123300
|
8-环戊基-7,8-二氢-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-7-氧代-吡啶并[2,3-D]嘧啶-6-甲腈
|
1357470-29-1
|
ONX-0912(Oprozomib)
|
ONX0912
|
935888-69-0
|
PAC-1
|
PAC1
|
315183-21-2
|
Palbociclib isethionate
|
帕布昔利布羟乙基磺酸盐
|
827022-33-3
|
Pardoprunox.HCl(SLV-308)
|
盐酸帕多芦诺
|
269718-83-4
|
PBIT
|
2 - (4 - Methylphenyl) - 1,2 - benzisothiazol - 3(2H)-one
|
2514-30-9
|
PBTZ169
|
PBTZ169
|
1377239-83-2
|
PD 153035(AG-1517)
|
4-[(3-溴苯基)氨基]-6,7-二甲氧基喹啉
|
153436-54-5
|
PD153035 HCl
|
PD153035 HCl
|
183322-45-4
|
PD168393
|
PD168393
|
194423-15-9
|
Pelitinib (EKB-569)
|
培利替尼
|
257933-82-7
|
Perifosine
|
哌立福辛
|
157716-52-4
|
PF-03394197
|
奥拉替尼
|
1208319-26-9
|
PF-04418948
|
PF04418948
|
1078166-57-0
|
PF-CBP1(PF-06670910) HCl
|
|
|
PFI-4
|
N-(1,3-二甲基-2-氧代-6-(吡咯烷-1-基)-2,3-二氢-1H-苯并[D]咪唑-5-基)-2-甲氧基苯甲酰胺
|
900305-37-5
|
PI3K-IN-2
|
PI3K/MTOR抑制剂
|
1225037-39-7
|
Pilaralisib (XL-147)
|
2-氨基-N-[3-[N-[3-[(2-氯-5-甲氧基苯基)氨基]喹喔啉-2-基]氨基磺酰基]苯基]-2-甲基丙酰胺
|
934526-89-3
|
Pimavanserin(ACP-103)
|
匹莫范色林
|
706779-91-1
|
Pirodavir (R 77975)
|
吡罗达韦
|
124436-59-5
|
PP2
|
PP2
|
172889-27-9
|
PP3
|
4-氨基-1-苯基吡唑[3,4-D]嘧啶
|
5334-30-5
|
PRT4165(NSC-600157)
|
PRT4165
|
31083-55-3
|
PTACH (NCH-51)
|
NCH-51
|
848354-66-5
|
PYR-41
|
PYR 41
|
418805-02-4
|
Pyridostatin(RR 82) trifluoroacetate
|
4-(2-氨基乙氧基)-N2,N6-二[4-(2-氨基乙氧基)-2-喹啉基]-2,6-吡啶二甲酰胺
|
1085412-37-8
|
QNZ
|
N4-[2-(4-苯氧基苯基)乙基]-4,6-喹唑啉二胺
|
545380-34-5
|
Quisinostat (JNJ-26481585) 2HCl
|
JNJ 26854165
|
875320-29-9
|
R-428
|
R428
|
1037624-75-1
|
Remodelin
|
REMODELIN
|
949912-58-7
|
Resiquimod
|
雷西莫特
|
144875-48-9
|
RGFP966
|
RGFP966
|
1357389-11-7
|
RI-2
|
化合物RI-2
|
1417162-36-7
|
Ritalin (Methylphenidate Hcl)
|
盐酸哌甲酯
|
298-59-9
|
Lorediplon
|
LOREDIPLON
|
917393-39-6
|
OTS-964
|
OTS964
|
1338545-07-5
|
PD-1/PD-L1 inhibitor 1
|
PD-1
|
1675201-83-8
|